Author: Carly Behm

J. Christopher Barry has spent his career focused in the medical technology industry at Medtronic and currently CEO of NuVasive.

From outgoing leaders to new board members, here are nine updates on executive leadership at spine and orthopedic device companies in the last 60 days.

The minimally invasive spinal implants market reached nearly $2 billion in 2020, and it's expected to hit close to $3 billion by 2027, according to iData Research.

Ortho Regenerative Technologies has extended its clinical hold on its Ortho-R drug, according to an Aug. 20 news release.

Alex Gorsky will step down as chair and CEO of Johnson & Johnson and serve as executive chairman effective Jan. 3, 2022.

Saqib Hasan, MD, of Oakland, Calif.-based Webster Orthopedics, is the first fellowship-trained full-endoscopic spine surgeon in the U.S.

Olympia (Wash.) Orthopaedic Associates will open a spine center, according to an Aug. 19 announcement in Thurston Talk.

More than 3.9 million patients are expected to be treated for degenerative disc disease in the U.S. by 2028, according to a report from Coherent Market Insights.

Princeton (W.Va.) Community Hospital added Stryker's Mako robot for hip and knee replacements, WVA News reported Aug. 18.

Robert Rothrock, MD, joined Baptist Health’s Miami Neuroscience Institute as neurosurgical director of spinal oncology, South Florida Hospital News reported Aug. 18.